Trials / NCT06517940
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
Underway, not enrolling Observational Natural history / observational
- Sponsor
- Sumitomo Pharma America, Inc.
- Treatment
- Not listed
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to no upper limit
- Enrollment
- 12 participants
- Started
- 2024-10-03
- Main results expected
- 2026-04-24
- Results posted
- Not yet
- Record last updated
- 2026-02-27
What the study is testing
The natural history in individuals with severe retinitis pigmentosa (RP) is variable and there remains an unmet need to better understand disease progression in this population. The goal of this study is to determine which visual assessments individuals with RP and low visual acuity can reliably perform and to evaluate the annual decline of visual function in severe RP.
Where it runs
United States (1)
- Mass Eye and Ear, Boston, Massachusetts